What are the diagnostic criteria for Parkinson-plus syndromes?

Parkinson-Plus Syndromes: Diagnostic Criteria

Parkinson-plus syndromes are diagnosed when patients present with core parkinsonian features (bradykinesia and rigidity) PLUS additional distinguishing clinical features that differentiate them from idiopathic Parkinson's disease, with poor or absent response to levodopa being a critical diagnostic clue 1.

Core Concept

Parkinson-plus syndromes (also called atypical parkinsonisms) share the fundamental motor features of Parkinson's disease but are distinguished by:

• Additional neurological deficits beyond typical PD
• Poor or no response to levodopa therapy
• More rapid disease progression
• Different underlying pathology (tauopathies vs synucleinopathies)

The Three Major Parkinson-Plus Syndromes

1. Multiple System Atrophy (MSA)

Clinical Diagnostic Criteria:

MSA-P subtype (Parkinsonian predominant):

• Extrapyramidal/parkinsonian features predominate
• Age of onset: 55-65 years
• Mean disease duration: ~6 years
• Cerebellar ataxia, pyramidal signs, and prominent dysautonomia (including urinary incontinence) 1

MSA-C subtype (Cerebellar predominant):

• Ataxia and cerebellar symptoms predominate
• Same autonomic dysfunction as MSA-P

MSA-A subtype (Autonomic predominant - Shy-Drager syndrome):

• Autonomic dysfunction is the primary feature
• Less common presentation

Pathology: Synucleinopathy with abnormal cytoplasmic inclusions of ubiquitin and alpha-synuclein in oligodendroglia 1

2. Progressive Supranuclear Palsy (PSP)

Clinical Diagnostic Criteria:

• Most common atypical parkinsonism (prevalence ~5/100,000)
• Age of onset: sixth or seventh decade (mean age 63)
• Presenting features: Lurching gait and axial dystonia manifested as unexplained falls early in disease 1
• Early ocular symptoms: Blurred vision and slow saccades
• Classic finding (appears later): Vertical supranuclear gaze palsy
• Axial rigidity more prominent than limb rigidity
• Symmetrical onset

Pathology: Tauopathy with abnormal tau protein accumulation 1

3. Corticobasal Degeneration (CBD)

Clinical Diagnostic Criteria:

• Age of onset: 50-70 years
• Initial presentation: Asymmetric limb clumsiness
• Progressive features:
  • Unilateral limb rigidity and dystonia
  • "Alien limb phenomenon" (pathognomonic feature)
  • Postural imbalance
  • Cortical features: Apraxia, cortical dementia, cortical sensory deficits, impaired language production 1

Pathology: Tauopathy 1

Key Distinguishing Features from Idiopathic PD

Red flags suggesting Parkinson-plus rather than PD:

• Symmetrical onset (PD is typically asymmetric)
• Absent or atypical tremor (rest tremor is classic in PD)
• Prominent axial rigidity (PD affects limbs more)
• Early postural instability and falls (occurs late in PD)
• Supranuclear gaze palsy (specific to PSP)
• Early autonomic failure (especially urinary incontinence in MSA)
• Pyramidal signs (not seen in PD)
• Cerebellar involvement (MSA-C)
• Alien limb phenomenon (CBD)
• Apraxia and cortical features (CBD)
• Early significant cognitive dysfunction
• Poor or no response to levodopa (critical distinguishing feature) 2, 3

Diagnostic Approach Algorithm

Step 1: Identify core parkinsonian features

• Bradykinesia (required)
• Rigidity
• Look for what's ABSENT: rest tremor often missing or atypical in Parkinson-plus

Step 2: Search for "plus" features

• Falls within first year → Consider PSP
• Prominent early autonomic dysfunction (especially urinary incontinence) → Consider MSA
• Asymmetric limb apraxia or alien limb → Consider CBD
• Vertical gaze palsy → PSP (though appears later)
• Cerebellar ataxia → MSA-C

Step 3: Assess levodopa response

• Poor or absent response strongly suggests Parkinson-plus rather than idiopathic PD 2, 4

Step 4: Confirm with imaging

• MRI brain is essential to demonstrate characteristic patterns of atrophy
• Ioflupane SPECT/CT can differentiate parkinsonian syndromes from essential tremor but cannot distinguish between PD and Parkinson-plus syndromes (all show dopaminergic depletion) 1

Critical Clinical Pitfalls

Common diagnostic errors to avoid:

1. Waiting for vertical gaze palsy in PSP - This classic finding appears LATE in disease; early falls and axial rigidity should trigger suspicion 1

2. Missing early autonomic dysfunction in MSA - Specifically ask about urinary incontinence, orthostatic hypotension, and erectile dysfunction 1

3. Assuming good levodopa response rules out Parkinson-plus - While poor response is typical, some patients may have modest initial benefit 2

4. Relying on imaging alone - Clinical diagnosis remains paramount; imaging supports but doesn't replace clinical criteria 1

5. Overlooking the alien limb phenomenon in CBD - This bizarre symptom may be dismissed by patients or attributed to other causes 1

Pathological Classification

Understanding the underlying pathology aids diagnosis:

Synucleinopathies:

• MSA (alpha-synuclein in oligodendroglia)
• Idiopathic PD (Lewy bodies)

Tauopathies:

• PSP
• CBD

This distinction has implications for future targeted therapies and helps explain why these disorders don't respond to dopaminergic therapy like PD does 1.

Prognosis Implications

Parkinson-plus syndromes have significantly worse prognosis than idiopathic PD:

• MSA: mean disease duration ~6 years 1
• More rapid progression than PD
• Poor quality of life due to multiple system involvement
• Limited treatment options beyond symptomatic management

Accurate early diagnosis is crucial for appropriate counseling, avoiding futile levodopa escalation, and implementing appropriate supportive care measures 2.